Medical devices, healthcare technology and the business of care
510(k) clearance · K260581

KARL STORZ Flexible Video Neuro-Endoscope

Karl Storz SE & CO. KG · Decision date Oct 14, 2026

MEDTECHLEDGER EXPLANATIONK260581

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 14 October 2026 for K260581, a 510(k) premarket notification submitted by Karl Storz SE & CO. KG of Tuttlingen, Germany. The submission was received on 20 February 2026 and reviewed under product code GWG in the Neurology medical specialty. SESE means the device was cleared as substantially equivalent to a predicate; it is not a premarket approval of the device.

The record identifies the subject as the KARL STORZ Flexible Video Neuro-Endoscope. The available source fields do not describe the specific components, design changes, or predicate device, and no summary statement is present, so the basis for the equivalence determination and any labeled indications remain unknown from this record. The listed page date of 2 November 2026 differs from the 14 October 2026 decision date; the reason is not stated in the source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260581
Regulatory pathway
510(k) premarket notification
Product code
GWG
Decision code
SESE
Decision date
Oct 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Endoscope, Neurological.

Product code
GWG
FDA device class
2

FDA decision timeline

  1. K260581 received

    Application receipt date recorded by FDA.

  2. K260581 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GWG

Product / regulatory recordCompanyPathwayDecision dateSource
VPIX MEDICAL, INC.510(k) clearanceOct 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Karl Storz SE & CO. KG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tuttlingen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records